Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder

被引：0
|
作者：
Lenard A Adler
David Goodman
Richard Weisler
Mohamed Hamdani
Thomas Roth
机构：
[1] New York University School of Medicine,Department of Psychiatry and Child and Adolescent Psychiatry
[2] Johns Hopkins University School of Medicine,Department of Psychiatry and Behavioral Sciences
[3] Duke University Medical Center,Department of Psychiatry
[4] University of North Carolina at Chapel Hill,Biostatistics
[5] Shire Pharmaceuticals Inc.,Sleep Disorders and Research Center
[6] Henry Ford Health System,undefined
来源：
Behavioral and Brain Functions | / 5卷
关键词：
Sleep Quality; Sleep Duration; ADHD Symptom; Atomoxetine; Pittsburgh Sleep Quality Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pharmacokinetic and Pharmacodynamic Properties of Lisdexamfetamine in Adults with Attention-Deficit/Hyperactivity Disorder
    Adler, Lenard A.
    Alperin, Samuel
    Leon, Terry
    Faraone, Stephen V.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (02) : 196 - 199
  • [32] Clinical Response and Symptomatic Remission in Children Treated With Lisdexamfetamine Dimesylate for Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Adeyi, Ben
    Chen, Gary
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Lasser, Robert
    Pucci, Michael L.
    Abdullah, Huda I.
    McGough, James J.
    [J]. CNS SPECTRUMS, 2010, 15 (09) : 559 - 568
  • [33] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Jain, Rakesh
    Babcock, Thomas
    Burtea, Teodor
    Dirks, Bryan
    Adeyi, Ben
    Scheckner, Brian
    Lasser, Robert
    Renna, John
    Duncan, Don
    [J]. ADVANCES IN THERAPY, 2013, 30 (05) : 472 - 486
  • [34] Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder
    Najib, Jadwiga
    Didenko, Ekaterina
    Meleshkina, Daria
    Yusupov, Kamila
    Maw, Kateryna
    Ramnarain, Justin
    Tabassum, Maliha
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1717 - 1735
  • [35] Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity
    Ginsberg, Lawrence
    Katic, Alain
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Lasser, Robert
    Scheckner, Brian
    Adler, Lenard A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1097 - 1107
  • [36] Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
    Popovic, Biljana
    Brattacharya, Pratik
    Sivaswamy, Lalitha
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (22) : 2005 - 2012
  • [37] European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Higgins, Nicholas
    Lyne, Andrew
    Squires, Liza
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (10) : 1208 - 1218
  • [38] Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder
    Ichikawa, Hironobu
    Miyajima, Tasuku
    Yamashita, Yushiro
    Fujiwara, Masakazu
    Fukushi, Akimasa
    Saito, Kazuhiko
    [J]. NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (01) : 52 - 62
  • [39] EFFICACY OF LISDEXAMFETAMINE DIMESYLATE IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: EFFECT OF AGE, SEX AND BASELINE DISEASE SEVERITY
    Lecendreux, M.
    Banaschewski, T.
    Soutullo, C.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Higgins, N.
    Bloomfield, R.
    Squires, L.
    Coghill, D.
    [J]. EUROPEAN PSYCHIATRY, 2013, 28
  • [40] Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Zuddas, A.
    Banaschewski, T.
    Nagy, P.
    Soutullo, C.
    Yan, B.
    Caballero, B.
    Coghill, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S648
12345